Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-12-12 | Primis Financial Corp. | Diaz Deborah
(Director) |
P | Common Stock | A | 2000 | $12.42 - $12.42 | $24,840 |
2024-12-18 | Orchestra BioMed Holdings, Inc. | Hochman David P
(See Remarks) |
P | Common Stock, par value $0.0001 per share ("Common Stock") | A | 5000 | $4.91 - $4.91 | $24,550 |
2024-12-13 | AVADEL PHARMACEUTICALS PLC | MCHUGH THOMAS S
(Chief Financial Officer) |
P | Ordinary Shares | A | 2300 | $10.44 - $10.44 | $24,018 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |